GILEAD SCIENCES, INC. quarter change: USA Bonds: Other Debt, Sold out
In other debt filed by principal amount (debentures, bonds) (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, GILEAD SCIENCES, INC. opened 0 positions, added to 0, reduced 0, sold out of 0 and left 0 unchanged.
Two Form 13F-HR filings compared (SEC CIK 882095): 2026-03-31 (filed 2026-05-08) and 2026-06-30 (filed 2026-08-03). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| BASSWOOD CAPITAL MANAGEMENT, L.L.C. | United States | $2.119B | 108 |
| BSN Capital Partners Ltd | $2.123B | 41 | |
| GW HENSSLER & ASSOCIATES LTD | United States | $2.123B | 232 |
| Index Venture Associates VI Ltd | Jersey | $2.109B | 3 |
| Empirical Finance, LLC | United States | $2.128B | 483 |
| KINGSWOOD WEALTH ADVISORS, LLC | United States | $2.107B | 924 |
| Hardman Johnston Global Advisors LLC | United States | $2.105B | 73 |
| CENTAURUS FINANCIAL, INC. | United States | $2.104B | 1,058 |
| Blue Whale Capital LLP | United Kingdom | $2.103B | 26 |
| Strategic Financial Services, Inc. | United States | $2.102B | 153 |